.jpg?itok=mqcCRg-W "Protagonist Therapeutics founder Associate Professor Mark Smythe")
Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.
31 October 2016
University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.
22 August 2016The University of Queensland-based Protagonist Therapeutics, Inc. has announced the completion of a $14 million Series B venture financing initiative.
10 July 2013A successful Brisbane biotechnology company formed by The University of Queensland’s Institute for Molecular Bioscience (IMB) is expanding its collaboration with a publicly traded pharmaceutical company based on the east coast of the United States.
10 December 2012
